These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 920936)

  • 1. Subnanogram estimation of the proximate carcinogen N-hydryxy-2-fluorenylacetamide by gas-liquid chromatography.
    Razzouk C; Lhoest G; Roberfroid M; Mercier M
    Anal Biochem; 1977 Nov; 83(1):194-203. PubMed ID: 920936
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of the structural isomer N-3-fluorenylacetamide on microsomal binding and hydroxylation of the carcinogen N-2-fluorenylacetamide.
    Chow YM; Gutmann HR; Kaplan E
    Biochem Pharmacol; 1981 Jun; 30(11):1253-61. PubMed ID: 7271824
    [No Abstract]   [Full Text] [Related]  

  • 3. Dietary lipid-dependent activation of the carcinogen N-2-fluorenylacetamide in rats as monitored by Salmonella typhimurium.
    Castro CE; Felkner IC; Yang SP
    Cancer Res; 1978 Sep; 38(9):2836-41. PubMed ID: 354780
    [No Abstract]   [Full Text] [Related]  

  • 4. Alteration of the ability of liver microsomes to activate N-2-fluorenylacetamide to a mutagen of Salmonella typhimurium during hepatocarcinogenesis.
    Stout DL; Becker FF
    Cancer Res; 1978 Aug; 38(8):2274-8. PubMed ID: 208764
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-2-aminofluorene by guinea pig liver microsomes.
    Razzouk C; Batardy-Grégoire M; Roberfroid M
    Cancer Res; 1982 Nov; 42(11):4712-8. PubMed ID: 7127306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids and their acetates.
    Malejka-Giganti D; Rydell RE; Gutmann HR
    Cancer Res; 1977 Jan; 37(1):111-7. PubMed ID: 830400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Hydroxylation of arylamides by the rat and guinea pig. Evidence for substrate specificity and participation of cytochrome P1-450.
    Gutmann HR; Bell P
    Biochim Biophys Acta; 1977 Jun; 498(1):229-43. PubMed ID: 884151
    [No Abstract]   [Full Text] [Related]  

  • 8. N'-hydroxy-2-aminofluorene: the principal mutagen produced from N-hydroxy-2-acetylaminofluorene by a mammalian supernatant enzyme preparation.
    Stout DL; Baptist JN; Matney TS; Shaw CR
    Cancer Lett; 1976 May; 1(5):269-74. PubMed ID: 797443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro metabolism and mutagenic activation of 2-acetylaminofluorene by subcellular liver fractions from Cotton rats.
    Schut HA; Thorgeirsson SS
    Cancer Res; 1978 Aug; 38(8):2501-7. PubMed ID: 352509
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of microsomal N-hydroxylation of N-2-fluorenylacetamide in rat liver.
    Malejka-Giganti D; McIver RC; Glasebrook AL; Gutmann HR
    Biochem Pharmacol; 1978 Jan; 27(1):61-9. PubMed ID: 413553
    [No Abstract]   [Full Text] [Related]  

  • 11. Microsomal metabolism of arylamides by the rat and guinea pig--I. Oxidation of N-3-fluorenylacetamide at carbon-atom-9--a major metabolic reaction.
    Kaplan E; Gutmann HR; Emory TH
    Biochem Pharmacol; 1978; 27(11):1581-9. PubMed ID: 697900
    [No Abstract]   [Full Text] [Related]  

  • 12. Mutagenic activation of N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide in subcellular fractions from X/Gf mice.
    Reddy TV; Weisburger EK; Thorgeirsson SS
    J Natl Cancer Inst; 1980 Jun; 64(6):1563-9. PubMed ID: 6929392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfation in the metabolism and mutagenicity of N-hydroxy-2-fluorenylacetamide.
    Hinson JA; Andrews LS; Gillette JR
    Natl Cancer Inst Monogr; 1981 Dec; (58):113-6. PubMed ID: 6176868
    [No Abstract]   [Full Text] [Related]  

  • 14. Microsomal metabolism of arylamides by the rat and guinea pig--II. Oxidation of 3-fluorenylacetamide at carbon atom 9. Formation of 3-acetamido-9-fluorenone.
    Kaplan E; Gutmann HR
    Biochem Pharmacol; 1979 May; 28(10):1609-14. PubMed ID: 38792
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative analysis of the ring-hydroxylated metabolites of 2-fluorenylacetamide by gas-liquid chromatography.
    Batardy-Grégoire M; Razzouk C; Evrard E; Roberfroid M
    Anal Biochem; 1982 May; 122(1):199-205. PubMed ID: 7103083
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms of the inhibitory action of p-hydroxyacetanilide on carcinogenesis by N-2-fluorenylacetamide or N-hydroxy-N-2-fluorenylacetamide.
    Mohan LC; Grantham PH; Weisburger EK; Weisburger JH; Idoine JB
    J Natl Cancer Inst; 1976 Apr; 56(4):763-8. PubMed ID: 815562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex hormone-mediated effects on the phase I and phase II metabolism of N-2-fluorenylacetamide. Modulation of 9-hydroxylation.
    Malejka-Giganti D; Magat WJ; Decker RW
    Biochem Pharmacol; 1989 Apr; 38(7):1075-82. PubMed ID: 2495797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and identification of the carcinogen N-hydroxy-2-fluorenylacetamide and related compounds by liquid chromatography.
    Gutmann HR
    Anal Biochem; 1974 Apr; 58(2):469-78. PubMed ID: 4827393
    [No Abstract]   [Full Text] [Related]  

  • 19. A simple high-pressure liquid chromatographic assay for the N-hydroxy derivatives of phenacetin, acetaminophen, 2-acetylaminofluorene, and other hydroxamic acids.
    Hinson JA; Pohl LR; Gillette JR
    Anal Biochem; 1980 Jan; 101(2):462-7. PubMed ID: 7362041
    [No Abstract]   [Full Text] [Related]  

  • 20. High-performance liquid chromatographic analysis of 2-aminofluorene and its metabolites in monolayer cultures of rat hepatocytes.
    Miller MJ; McQueen CA
    Anal Biochem; 1986 Feb; 153(1):39-44. PubMed ID: 3963381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.